1.
J Indian Med Assoc
;
2006 Jan; 104(1): 42, 44
Article
Dans Anglais
| IMSEAR
| ID: sea-97378
Résumé
Recombinant factor VIIa is a novel haemostatic agent and was originally developed to treat haemophilia patients. Successful use of the factor in a 30-year-old male patient with pelvic fracture haemorrhage is being described by the authors.